In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Osprey Pharmaceutical Co.

Division of CoMentis Inc.

Latest From Osprey Pharmaceutical Co.

Attack of the Killer Bs

2006 has seen an unusual number of large Series B venture rounds in biopharma compared to last year, though Series B rounds haven't been much larger on average.
BioPharmaceutical Strategy

Deals Shaping the Medical Industry (5/06)

The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Windhover's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • CoMentis Inc.
  • Senior Management
  • Paul Herron, VP and CFO
    Cynthia Brody, VP
  • Contact Info
  • Osprey Pharmaceutical Co.
    Phone: (904) 273-5836
    830-13 A1A North
    Suite 274
    Ponte Vedra Beach, FL 32082
    USA
UsernamePublicRestriction

Register